Table 1 Characteristics of the study population a
Characteristics | RA | OA |
|---|---|---|
Number of patients (M/F) | 18 (11/7) | 22 (13/9) |
Age (yr) | 67.5 ± 8 | 66.7 ± 8.3 |
Duration of disease (yr) | 14 ± 7 | 15 ± 6 |
DAS28 score | 4.5 ± 1.2 | n.a. |
RF-positive, n (%) | 10 (55.6) | n.a. |
CRP (mg/L) | 17 ± 9 | 5.1 ± 3 |
ESR (mm/h) | 23 ± 12 | 4 ± 2 |
DMARD, n (%) | 14 (77.8) | 0 |
Anti-TNF treatment, n (%) | 5 (27.8) | 0 |
Glucocorticoids, n (%) | 1 (5.6) | 0 |
NSAID, n (%) | 16 (88.9) | 20 (90.1) |